Clinical application of pharmacogenetic-based warfarin-dosing algorithm in patients of Han nationality after rheumatic valve replacement: a randomized and controlled trial.
about
Pharmacogenetic-guided dosing of coumarin anticoagulants: algorithms for warfarin, acenocoumarol and phenprocoumonHigh resolution melting method to detect single nucleotide polymorphism of VKORC1 and CYP2C9.A pharmacogenetics-based warfarin maintenance dosing algorithm from Northern Chinese patients.Improved drug therapy: triangulating phenomics with genomics and metabolomics.Pharmacogenetics-Based versus Conventional Dosing of Warfarin: A Meta-Analysis of Randomized Controlled Trials.Meta-analysis of Randomized Controlled Trials of Genotype-Guided vs Standard Dosing of Warfarin.Clinical effects of Xinmailong therapy in patients with chronic heart failure.A pharmacogenetic versus a clinical algorithm for warfarin dosing.Genotype-guided drug prescribing: a systematic review and meta-analysis of randomized control trials.Genotype-guided coumarin dosing: where are we now and where do we need to go next?Warfarin pharmacogenomics: current best evidence.Incorporating Pharmacogenomics into Health Information Technology, Electronic Health Record and Decision Support System: An Overview.Verification of five pharmacogenomics-based warfarin administration models.Effect of CYP2C9, VKORC1, CYP4F2 and GGCX genetic variants on warfarin maintenance dose and explicating a new pharmacogenetic algorithm in South Indian population.Effect of Genotype-Guided Warfarin Dosing on Clinical Events and Anticoagulation Control Among Patients Undergoing Hip or Knee Arthroplasty: The GIFT Randomized Clinical Trial.Limited clinical utility of genotype-guided warfarin initiation dosing algorithms versus standard therapy: a meta-analysis and trial sequential analysis of 11 randomized controlled trials.Meta-analysis of randomized controlled trials reveals an improved clinical outcome of using genotype plus clinical algorithm for warfarin dosing.Genotype-guided warfarin dosing vs. conventional dosing strategies: a systematic review and meta-analysis of randomized controlled trials
P2860
Q27006860-8103FB9B-E1D3-4F60-97F7-020511E21332Q33802999-15B6EA4D-DC4F-42BF-8ABE-036DFE91F7AAQ34050936-6CA24304-63EE-4108-BA3A-0C89542C6320Q34436487-6EC8E192-9002-44D5-B2FB-6FB1AF73C5D8Q35870028-AD748099-131F-481B-A746-798199865CD7Q36015458-CBA728BD-4D6B-4373-B9EC-FEF23C59EC95Q36746865-80531FC7-3CD0-496E-9C9C-3AE25B2BE9A5Q37616712-BF59ACFF-3DEE-479E-A5B7-AE393ECD6C26Q38233757-486E148B-88C5-48A4-8EF0-DD1C8B3C5D0EQ38321269-3686747D-1FE0-4DA0-AA02-D57239D8E308Q38543302-393B2AD3-4D22-437B-86D3-AFF1E978BB9DQ39041940-81BE77AC-9D16-4386-9526-4A82867D4D26Q42736252-1764AD80-7ED9-4A19-BBA6-094D03B22B20Q44495777-5C102FB6-F91A-41B0-A4FE-CF7A90E4FC09Q48580819-7A667788-F343-49D0-A6E6-26408642456BQ49110792-35D053EE-325E-4C89-9B2B-499D88963703Q51072095-1E3219B1-C08B-42CC-A423-A0EDB8F9769BQ58827166-E8BED7F3-67A9-40D8-A590-EA261CC99512
P2860
Clinical application of pharmacogenetic-based warfarin-dosing algorithm in patients of Han nationality after rheumatic valve replacement: a randomized and controlled trial.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Clinical application of pharma ...... ndomized and controlled trial.
@ast
Clinical application of pharma ...... ndomized and controlled trial.
@en
type
label
Clinical application of pharma ...... ndomized and controlled trial.
@ast
Clinical application of pharma ...... ndomized and controlled trial.
@en
prefLabel
Clinical application of pharma ...... ndomized and controlled trial.
@ast
Clinical application of pharma ...... ndomized and controlled trial.
@en
P2093
P2860
P356
P1476
Clinical application of pharma ...... ndomized and controlled trial.
@en
P2093
LiangJian Zou
LiangXu Wang
MingSong Wang
ShengHui Zhang
ShiTao Cui
XiLong Lang
XinTian Wu
P2860
P304
P356
10.7150/IJMS.4637
P407
P577
2012-08-10T00:00:00Z